Home  /  Daily Current Affairs  /  31-12-2021 / CORBEVAXTM

CORBEVAXTM

Posted on December 31, 2021 by admin1  639

In News 

Recently, CORBEVAXTM received approval for Emergency Use Authorization (EUA)

by Drug Controller General of India (DCGI).

Drugs Controller General of India

  • It is the apex department of the Central Drugs Standard Control Organization (CDSCO) of the Government of India.
    • CDSCO is a regulatory body for Indian pharmaceuticals and medical devices.
    • It comes under the Ministry of Health and Family Welfare.
  • Functions:
    • Approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines and sera in India.
    • Sets standards for the manufacturing, sales, import, and distribution of drugs in India.

Emergency Use Authorization (EUA)

  • It is an authorization issued for unregistered drugs and vaccines in a public health emergency.

About CORBEVAXTM

  • It is India’s first indigenously developed Receptor Binding Domain (RBD) protein subunit vaccine for COVID-19.
  • It is a 2-dose vaccine administered intramuscularly and can be stored at 2ºC to 8ºC.
  • It is developed by Biological E Limited.
    • The Department of Biotechnology (DBT) and its Public Sector Undertaking (PSU), Biotechnology Industry Research Assistance Council (BIRAC), have supported Biological E’s COVID-19 vaccine candidate from the preclinical stage through Phase III clinical studies. 
  • Financial Support: The vaccine candidate was provided financial support under COVID-19 Research Consortium, through the National Biopharma Mission, for preclinical toxicology studies. 
    • Later support was provided under Mission COVID Suraksha for clinical development. 
  • The recombinant protein subunit vaccine developed from the Receptor Binding Domain (RBD) of the spike protein on the viral surface is adjuvanted with Dynavax’s CpG 1018 and alum. 
  • Result of Phase III clinical trials 
    • Comprehensive Phase III clinical trials involving more than 3000 subjects between the ages of 18 and 80 at 33 study sites across India, demonstrated the vaccine to be safe, well-tolerated and highly immunogenic. 
  • Significance 
    • This vaccine will sharpen the country’s efforts in ending the pandemic. The development of indigenous vaccines to fight the pandemic will also inspire the country’s scientists and manufacturers to resolve the problems of the country.

Mission COVID Suraksha Program

  • The Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India (GoI) has taken myriads of initiatives to increase investments in research & development (R&D) and manufacturing of COVID-19 Vaccines. 
  • The establishment of the Mission COVID Suraksha Program is one such endeavour for COVID-19 vaccine development to reinforce and streamline available resources towards a warpath for accelerated vaccine development, leading to bringing in a safe, efficacious, affordable and accessible COVID-19 Vaccine for the citizens at the earliest with a target of Atmanirbhar Bharat.
  • COVID Suraksha Program’s endeavour to accelerate vaccine development played a crucial role in the initial development, the mechanism that was set up with the support of the Department of Biotechnology and DBT-Biotechnology Industry Research Assistance Council (BIRAC) allowed us to scale up to a capacity of about 1.2 billion doses per annum making the dream of accessibility – affordability and supply – a reality.”

The National Biopharma Mission (NBM)

  • It is an Academia-Industry Collaborative Mission for Accelerating Discovery Research to Early Development for Biopharmaceuticals. 
  • The objective of the Mission is to enable and nurture an ecosystem for preparing India’s technological and product development capabilities in biopharmaceuticals including vaccines, biologics, medical devices and diagnostics to a level that will be globally competitive over the next decade.
  • The dedicated Program Management Unit (PMU) at Biotechnology Industry Research Assistance Council (BIRAC) under the aegis of the Department of Biotechnology is the Implementing Agency for the Mission. 
  • Under the National Biopharma Mission, skill development training programmes shall be facilitated for young professionals to build next-generation inter-disciplinary skills for product innovation, knowledge of navigating regulatory policies, business development capabilities, better management of IPR systems and practices for building effective workforce and next-generation leaders through close engagement and collaboration of industry and academic training partners.

Source: PIB

 
Previous article Nord Stream 2 Pipeline is ready for operation
Next article Chakmas and Hajongs

Other News of the Day

In News  The Odisha Forest and Environment Department has completed its first-ever radio-tagging of the Indian pangolin in an attempt to standardise the rehabilitation protocol for the animal in the State. About  Scientific Name: Manis crassicaudata the Indian pangolin is the largest among eight pangolin species.  Description: It has large, overlapping scales on its body...
Read More

In News  Recently, The income tax department has revised its faceless appeal scheme. Originally, the scheme was launched in September 2020.  About  ‘Faceless Appeal Scheme, 2021’ It was notified by The Central Board of Direct Taxes (CBDT). Under the previous scheme, a taxpayer’s request for a personal hearing for making oral submissions, required the approval...
Read More

In News  Atal Innovation Mission (AIM) NITI Aayog released the second edition of – ‘Innovations for You’ and ‘The Ingenious Tinkerers’. Both the books are celebrations of the success stories of young innovators of India. About  ‘Innovations for You is a compendium of innovations focused on agriculture featuring 70 startups supported by Atal incubation Centers...
Read More

In News  Sankalp Smarak was dedicated to the nation by Commander-in-Chief Andaman and Nicobar Command (CINCAN), exactly 78 years after Netaji Subhas Chandra Bose’s arrival on 29 Dec 2021. About  Sankalp Smarak  It is a tribute not only to the resolve of the soldiers of the Indian National Army and their innumerable sacrifices but also...
Read More

Context  The Ministry of Social Justice and Empowerment is expected to launch a SMILE  Scheme for the rehabilitation of persons engaged in begging and for providing support to transgender persons. About SMILE Scheme It includes two sub-schemes - ‘Central Sector Scheme for Comprehensive Rehabilitation for Welfare of Transgender Persons’ and ‘Central Sector Scheme for Comprehensive...
Read More

Context  Prime Minister of India will release the 10th instalment of financial benefit under the Pradhan Mantri Kisan Samman Nidhi (PM-KISAN) scheme on 1st January 2022  This will enable the transfer of an amount of more than Rs. 20,000 crore to more than 10 crore beneficiary farmer families. Pradhan Mantri Kisan Samman Nidhi (PM-KISAN) It...
Read More

Context  Latest genome sequencing in Mumbai finds one-third of samples positive for Omicron. What Is Genome Sequencing? A genome is a complete set of genetic instructions which are present in an organism in its DNA. Sequencing is the sequence of occurrences of the four nucleotide bases i.e., adenine (A), cytosine (C), guanine (G), and thymine...
Read More

In News Social activists working among farmers have come out against the Food Safety and Standards Authority of India's (FSSAI) draft regulations on genetically modified (GM) food. Major Highlights of Draft Regulations:  Labelling: FSSAI had proposed all food products having individual genetically engineered ingredients of 1% or more to be labelled as "Contains GMO/Ingredients derived...
Read More

In News Recently, a positive indigenisation list of sub-systems/assemblies/subassemblies/components has been notified by the Ministry of Defence.  Major Points  The products will only be procured from Indian Industry after the timelines indicated in the list. The list contains 2,500 imported items that have already been indigenised and 351 imported items which will be indigenised in...
Read More